ImmunoPrecise Antibodies (IPA)
NASDAQ:IPA
Holding IPA?
Track your performance easily

ImmunoPrecise Antibodies (IPA) Balance Sheet

144 Followers

ImmunoPrecise Antibodies Balance Sheet

ImmunoPrecise Antibodies's total assets for Q1 2025 were C$59.30M, a decrease of -1.07% from the previous quarter. IPA total liabilities were C$26.45M for the fiscal quarter, a 1.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Apr 24Apr 23Apr 22Apr 21Apr 20
Total Assets
C$ 59.94MC$ 77.81MC$ 93.65MC$ 66.96MC$ 27.26M
Total Liabilities
C$ 26.07MC$ 20.01MC$ 18.36MC$ 10.04MC$ 12.18M
Total Equity Gross Minority
C$ 33.92MC$ 57.80MC$ 75.28MC$ 56.92MC$ 15.09M
Total Capitalization
C$ 33.92M-C$ 75.28MC$ 58.45MC$ 15.59M
Preferred Stock Equity
-----
Capital Lease Obligations
-----
Currency in CAD

ImmunoPrecise Antibodies Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis